National Institute of Allergy and Infectious Diseases; Notice of Meeting

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

June 9, 2026

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 110 (Tuesday, June 9, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 110 (Tuesday, June 9, 2026)]
[Notices]
[Page 34828]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-11477]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the AIDS Research 
Advisory Committee, NIAID.
    The meeting will be open to the public. The open sessions will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
website (<a href="http://videocast.nih.gov">http://videocast.nih.gov</a>). Individuals who plan to attend and 
need special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the Contact Person listed 
below in advance of the meeting.

    Name of Committee: AIDS Research Advisory Committee, NIAID.
    Date: June 22, 2026.
    Time: 1:00 p.m. to 5:00 p.m.
    Agenda: Report of Division Director and Division Staff.
    Address: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Grand Hall 
Rockville, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Martin Gutierrez, Program Coordinator, 
Scientific Planning and Operations Division of AIDS, National 
Institute of Allergy and Infectious Diseases, National Institutes of 
Health, 5601 Fishers Lane, Room 8D50, Rockville, MD 20892-9831, 240-
292-4844, <a href="/cdn-cgi/l/email-protection#f69b9183829f938484938cb69b979f9ad8989f9ed8919980"><span class="__cf_email__" data-cfemail="e28f8597968b8790908798a28f838b8ecc8c8b8acc858d94">[email&#160;protected]</span></a>.

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.

    Dated: June 4, 2026.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-11477 Filed 6-8-26; 8:45 am]
BILLING CODE 4167-05-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on June 9, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.